We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

Biosimilars in Canada: new draft guidelines from Health Canada
  • Torys LLP
  • Canada
  • July 21 2009

Health Canada announced that it had granted marketing authorization for Omnitrope (a human growth hormone), the first subsequent entry biologic (SEB) to be approved for sale in Canada


Health Canada’s guidance document on PM(NOC) Regulations now finalized
  • Torys LLP
  • Canada
  • April 4 2012

Health Canada has published an update to its guidance document on the application of the Patented Medicines (Notice of Compliance) Regulations


Canada's version of the responsible corporate officer doctrine: can officers be held responsible for pharma violations?
  • Torys LLP
  • Canada, USA
  • February 29 2012

In March 2010, the United States Food and Drug Administration (FDA) announced its intention to rely more heavily on the "responsible corporate officer" (RCO) doctrine to prosecute individuals for violations of the federal Food, Drug and Cosmetic Act (FDCA


Product liability litigation: bar raised for class action certification?
  • Torys LLP
  • Canada
  • May 10 2012

In a decision released May 7, 2012, Justice Caroline Horkins of the Superior Court of Ontario has refused to certify a proposed class proceeding in a pharmaceutical product liability claim (Martin et al. v. Astrazeneca Pharmaceuticals PLC et al


Canada's approach to functional foods
  • Torys LLP
  • Canada
  • April 21 2010

Today’s diet- and health-conscious environment has led to a proliferation of functional food marketing claims that advertise the specific health-enhancing characteristics of a food product


Canadian privacy commissioners release guidance on workplace H1N1 privacy
  • Torys LLP
  • Canada
  • November 18 2009

On October 29, 2009 the Office of the Privacy Commissioner of Canada (OPC), together with the Privacy Commissioners’ offices of Alberta and British Columbia, published a guidance document titled "Privacy in the Time of a Pandemic: Guidance for Organizations."


More biopharma M&A in 2010, but healthy or distressed?
  • Torys LLP
  • Canada
  • December 31 2009

As blockbuster drugs began to come off patent, big pharmas fearing loss of revenue share rushed to couple with their counterparts in 2009


Producers to manage pharmaceuticals and sharps returned by consumers
  • Torys LLP
  • Canada
  • November 2 2012

On October 1, 2012, Collection of Pharmaceuticals and Sharps Responsibilities of Producers regulation (O. Reg. 29812) came into force


Ontario case on product liability shows the immense scope of a class action trial
  • Torys LLP
  • Canada
  • July 5 2012

In a highly anticipated decision released on June 26, 2012, the Ontario Superior Court of Justice ruled in favour of the defendants in Andersen v. St. Jude Medical, Inc., Ontario’s first medical product liability class action trial


Promotion of drugs and devices at international conferences held in Canada
  • Torys LLP
  • Canada
  • February 3 2009

As a neighbor, Canada is often selected as a venue for international conferences of U.S. drug and device manufacturers